Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

著者: Joyce F. Liu, William T. Barry, Michael J. Birrer, Jung Min Lee, Ronald J. Buckanovich, Gini F. Fleming, B.J. Rimel, Mary K. Buss, Sreenivasa Nattam, Jean Hurteau, Weixiu Luo, Philippa Quy, Christin Whalen, Lisa Obermayer, Hang Lee, Eric P. Winer, Elise C. Kohn, S. Percy Ivy, Ursula A. Matulonis - The Lancet 2014 被引用: 584